Research News
View articles by month and year
-
Tamoxifen and Chemo Reduce Risk of New, Second Cancer
Tamoxifen and chemotherapy reduce the risk of developing a new, second breast cancer in the other breast.
-
Reconstruction After Breast Cancer Surgery Usually Not Discussed
Most surgeons don't talk about reconstruction with women diagnosed with breast cancer. But when reconstruction is discussed, it makes a big difference in which type of surgery is chosen.
-
No Clear Link Between Eating Fat and Risk
While there is no clear link between the amount of fat a woman eats and her risk of breast cancer, a new study shows that a diet high in unsaturated fat seems to reduce the risk of breast cancer in women older than 50.
-
Can Acupuncture Help Hot Flashes?
A new study still offers mixed results on whether acupuncture can help ease hot flashes.
-
Schizophrenia Appears to Increase Breast Cancer Risk
New researcher shows that people diagnosed with schizophrenia have a 50% higher risk of breast cancer.
-
Breast Cancer Risk Affected by Depression?
Researchers look for link between depression and breast cancer risk.
-
Circulating Tumor Cell Levels Show Treatment Is Working
Measuring circulating tumor cells in the bloodstream may offer doctors a way to tell is chemotherapy is working against metastatic breast cancer.
-
Tykerb and Xeloda Effective on Breast Cancer in Brain
A small study shows that Tykerb (chemical name: lapatinib) combined with Xeloda (chemical name: capecitabine) can stop the growth of HER2-positive breast cancer that has spread to the brain.
-
Arimidex More Effective Than Tamoxifen for Postmenopausal Women
Another year of results from the ATAC trial continues to show that Arimidex has more benefits than tamoxifen for post-menopausal women diagnosed with early-stage, hormone-receptor-positive breast cancer.
-
Taxotere Combo Improves Survival
The combination of Taxotere (chemical name: docetaxel) and Cytoxan (chemical name: cyclophosphamide) offers better survival and fewer and less severe side effects than the combination of Adriamycin (chemical name: doxorubicin) and Cytoxan for treating breast cancer.
